Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 8 pseudogene 7 (KRT8P7) is classified as a processed pseudogene, meaning it is a DNA sequence similar to the functional keratin 8 gene but lacks protein-coding capability and is non-functional. Pseudogenes like KRT8P7 are typically remnants of once-functional genes that have lost their ability to produce protein due to mutations or lack of regulatory sequences. There is no evidence that KRT8P7 is a therapeutic target, encodes a protein, or has a biological or pathological function. Its existence is a result of the evolutionary multiplication and dispersion of keratin gene sequences in the human genome. KRT8P7 is derived from the keratin 8 (KRT8) gene, which is a functional type II intermediate filament protein critical for epithelial cytoskeleton and involved in various cellular structural and stress-response functions. However, KRT8P7 itself does not participate in these functions. KRT8P7 does not encode a receptor, enzyme, or functional protein, and thus is not considered a therapeutic target in drug discovery, nor noted in disease associations, biomarker use, or as a molecule of safety concern. The structure and naming conform to standardized gene nomenclature, with "pseudogene" and a numerical suffix indicating its processed, non-functional status, distinguishing it from the functional KRT8 gene. Unlike functional keratins, KRT8P7 is not implicated in any biological process, disease mechanism, or pharmacological interaction, nor does it serve as a biomarker. In summary, Keratin 8 pseudogene 7 (KRT8P7) is a non-coding, non-functional processed pseudogene related to keratin 8, not a drug target or receptor, and has no biological or clinical utility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 8 pseudogene 7 (KRT8P7).